Platine and EpiVax are co-organizing their 2nd seminar on Immunogenicity and Tolerance on October 24th, 2016. The conference agenda is shown below.
This meeting will focus on the determinants of immunogenicity – a key feature of effective vaccines and a key barrier to success in the clinic for protein therapeutics. Conversely, tolerance induction is a key feature of successful protein therapeutics, while suppressing immune responses to vaccines. The reduction of T cell epitopes and introduction of Treg epitopes (like Tregitopes) for protein therapeutics, and the reverse process for vaccines, will be discussed and illustrated in case studies. An award for the best presentation will be chosen by the audience.
What: Immunogenicity and Tolerance Seminar
When: Monday, October 24th, 2016
Where: Hilton Apollolaan
Cost: €75.00 (covers the food/venue – this is a not-for-profit event)
Platine and EpiVax have created a one-of-a-kind forum for discussion on current approaches in immunogenicity and tolerance induction, with a focus on biologics and vaccines. Co-organizers will include Immuno Valley, Lyon Biopole and MabDesign. The small size of this forum fosters a personal environment where participants engage each other and have the opportunity to connect with the presenters.
